Cargando…

A Multi‐Step Model of Parkinson's Disease Pathogenesis

BACKGROUND: Parkinson's disease (PD) may result from the combined effect of multiple etiological factors. The relationship between disease incidence and age, as demonstrated in the cancer literature, can be used to model a multistep pathogenic process, potentially affording unique insights into...

Descripción completa

Detalles Bibliográficos
Autores principales:	Le Heron, Campbell, MacAskill, Michael, Mason, Deborah, Dalrymple‐Alford, John, Anderson, Tim, Pitcher, Toni, Myall, Daniel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons, Inc. 2021
Materias:	Regular Issue Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9290013/ https://www.ncbi.nlm.nih.gov/pubmed/34374460 http://dx.doi.org/10.1002/mds.28719

Ejemplares similares

Changes of plasma cGP/IGF‐1 molar ratio with age is associated with cognitive status of Parkinson disease
por: Fan, Dawei, et al.
Publicado: (2020)

Caregiver burden is increased in Parkinson’s disease with mild cognitive impairment (PD-MCI)
por: Jones, Ann J., et al.
Publicado: (2017)

Positive Association of Ascorbate and Inverse Association of Urate with Cognitive Function in People with Parkinson’s Disease
por: Spencer, Emma S., et al.
Publicado: (2020)

Tracking Parkinson’s Disease over One Year with Multimodal Magnetic Resonance Imaging in a Group of Older Patients with Moderate Disease
por: Melzer, Tracy R., et al.
Publicado: (2015)

Different PD-MCI criteria and risk of dementia in Parkinson’s disease: 4-year longitudinal study
por: Wood, Kyla-Louise, et al.
Publicado: (2016)

Altered nucleus accumbens functional connectivity precedes apathy in Parkinson’s disease
por: Morris, Lee-Anne, et al.
Publicado: (2023)

Sensorimotor integration assessment by the Symbol-Digit modalities test in patients with Parkinson’s disease
por: Alamri, Yassar, et al.
Publicado: (2019)

Dimensions of apathy in Parkinson's disease
por: Thompson, Nasya, et al.
Publicado: (2023)

Reduced striatal volumes in Parkinson’s disease: a magnetic resonance imaging study
por: Pitcher, Toni L, et al.
Publicado: (2012)

Comparison of cognitive and UHDRS measures in monitoring disease progression in Huntington’s disease: a 12-month longitudinal study
por: Toh, Eng A, et al.
Publicado: (2014)

Acquired Stuttering in Parkinson's Disease
por: Gooch, Eloïse A., et al.
Publicado: (2023)

Beta Amyloid Deposition Is Not Associated With Cognitive Impairment in Parkinson's Disease
por: Melzer, Tracy R., et al.
Publicado: (2019)

Commentary: Aiming for Study Comparability in Parkinson's Disease: Proposal for a Modular Set of Biomarker Assessments to be Used in Longitudinal Studies
por: Alamri, Yassar, et al.
Publicado: (2017)

Supplementation of Blackcurrant Anthocyanins Increased Cyclic Glycine-Proline in the Cerebrospinal Fluid of Parkinson Patients: Potential Treatment to Improve Insulin-Like Growth Factor-1 Function
por: Fan, Dawei, et al.
Publicado: (2018)

Trends in Antiparkinsonian Medication Use in New Zealand: 1995–2011
por: Pitcher, T. L., et al.
Publicado: (2014)

Plasma exosome concentration may correlate with cognitive impairment in Parkinson's disease
por: Alamri, Yassar, et al.
Publicado: (2016)

Common Variants Coregulate Expression of GBA and Modifier Genes to Delay Parkinson's Disease Onset
por: Schierding, William, et al.
Publicado: (2020)

International Multicenter Analysis of Brain Structure Across Clinical Stages of Parkinson's Disease
por: Laansma, Max A., et al.
Publicado: (2021)

Whose name is it anyway? Varying patterns of possessive usage in eponymous neurodegenerative diseases
por: MacAskill, Michael R., et al.
Publicado: (2013)

Disordered Decision Making: A Cognitive Framework for Apathy and Impulsivity in Huntington's Disease
por: Morris, Lee‐Anne, et al.
Publicado: (2022)

Non-Contact Hand Movement Analysis for Optimal Configuration of Smart Sensors to Capture Parkinson’s Disease Hand Tremor
por: Khwaounjoo, Prashanna, et al.
Publicado: (2022)

Cyclic Glycine-Proline (cGP) Normalises Insulin-Like Growth Factor-1 (IGF-1) Function: Clinical Significance in the Ageing Brain and in Age-Related Neurological Conditions
por: Guan, Jian, et al.
Publicado: (2023)

DNAJC6 Mutations Disrupt Dopamine Homeostasis in Juvenile Parkinsonism‐Dystonia
por: Ng, Joanne, et al.
Publicado: (2020)

Gastrointestinal Symptoms and Dopamine Transporter Asymmetry in Early Parkinson's Disease
por: Murtomäki, Kirsi, et al.
Publicado: (2022)

Variations in the patterns of prevalence and therapy in Australasian Parkinson’s disease patients of different ethnicities
por: Alamri, Yassar, et al.
Publicado: (2020)

The Rostock International Parkinson's Disease (ROPAD) Study: Protocol and Initial Findings
por: Skrahina, Volha, et al.
Publicado: (2020)

Development and Validation of Automated Magnetic Resonance Parkinsonism Index 2.0 to Distinguish Progressive Supranuclear Palsy‐Parkinsonism From Parkinson's Disease
por: Quattrone, Andrea, et al.
Publicado: (2022)

Low‐fat versus ketogenic diet in Parkinson's disease: A pilot randomized controlled trial
por: Phillips, Matthew C.L., et al.
Publicado: (2018)

Combining multi‐omics analysis to identify host‐targeted targets for the control of Brucella infection
por: Yu, Jiuwang, et al.
Publicado: (2023)

Black and African American Connections to Parkinson's Disease Study: Addressing Missing Diversity in Parkinson's Disease Genetics
por: Bandres‐Ciga, Sara
Publicado: (2022)

Biased Connectivity of Brain-wide Inputs to Ventral Subiculum Output Neurons
por: Wee, Ryan W.S., et al.
Publicado: (2020)

Hippocampal Circuits for the Hunger-Dependent Control of Feeding Behaviour
por: Shien Wee, Ryan Wei, et al.
Publicado: (2021)

The Parkinson's Disease DNA Variant Browser
por: Kim, Jonggeol J., et al.
Publicado: (2021)

Diabetes and Neuroaxonal Damage in Parkinson's Disease
por: Vijiaratnam, Nirosen, et al.
Publicado: (2022)

The Myelin‐Weighted Connectome in Parkinson's Disease
por: Boshkovski, Tommy, et al.
Publicado: (2021)

Aromatic L‐Amino Acid Decarboxylase Gene Therapy Enhances Levodopa Response in Parkinson's Disease
por: Nutt, John G., et al.
Publicado: (2020)

Neuromelanin, aging, and neuronal vulnerability in Parkinson's disease
por: Vila, Miquel
Publicado: (2019)

The Impact of Type 2 Diabetes in Parkinson's Disease
por: Athauda, Dilan, et al.
Publicado: (2022)

GP2: The Global Parkinson's Genetics Program
Publicado: (2021)

Orthostatic Hypotension: A Prodromal Marker of Parkinson's Disease?
por: Dommershuijsen, Lisanne J., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_t7kj135cmvc2huekrh3hiiip17